These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

515 related items for PubMed ID: 29524972

  • 1. Sociodemographic and survival disparities for histologic variants of bladder cancer.
    Jue JS, Koru-Sengul T, Moore KJ, Miao F, Alameddine M, Nahar B, Punnen S, Parekh DJ, Ritch CR, Gonzalgo ML.
    Can J Urol; 2018 Feb; 25(1):9179-9185. PubMed ID: 29524972
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Positive surgical margins in soft tissue following radical cystectomy for bladder cancer and cancer specific survival.
    Dotan ZA, Kavanagh K, Yossepowitch O, Kaag M, Olgac S, Donat M, Herr HW.
    J Urol; 2007 Dec; 178(6):2308-12; discussion 2313. PubMed ID: 17936804
    [Abstract] [Full Text] [Related]

  • 7. The Impact of Plasmacytoid Variant Histology on the Survival of Patients with Urothelial Carcinoma of Bladder after Radical Cystectomy.
    Li Q, Assel M, Benfante NE, Pietzak EJ, Herr HW, Donat M, Cha EK, Donahue TF, Bochner BH, Dalbagni G.
    Eur Urol Focus; 2019 Jan; 5(1):104-108. PubMed ID: 28753857
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Impact of histological variants on oncological outcomes of patients with urothelial carcinoma of the bladder treated with radical cystectomy.
    Xylinas E, Rink M, Robinson BD, Lotan Y, Babjuk M, Brisuda A, Green DA, Kluth LA, Pycha A, Fradet Y, Faison T, Lee RK, Karakiewicz PI, Zerbib M, Scherr DS, Shariat SF.
    Eur J Cancer; 2013 May; 49(8):1889-97. PubMed ID: 23466126
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Comparative performance of comorbidity indices for estimating perioperative and 5-year all cause mortality following radical cystectomy for bladder cancer.
    Boorjian SA, Kim SP, Tollefson MK, Carrasco A, Cheville JC, Thompson RH, Thapa P, Frank I.
    J Urol; 2013 Jul; 190(1):55-60. PubMed ID: 23313198
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Upstaging of nonurothelial histology in bladder cancer at the time of surgical treatment in the National Cancer Data Base.
    Cohen AJ, Packiam V, Nottingham C, Steinberg G, Smith ND, Patel S.
    Urol Oncol; 2017 Jan; 35(1):34.e1-34.e8. PubMed ID: 27592529
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The impact of variant histological differentiation on extranodal extension and survival in node positive bladder cancer treated with radical cystectomy.
    Marks P, Gild P, Soave A, Janisch F, Minner S, Engel O, Vetterlein MW, Shariat SF, Sauter G, Dahlem R, Fisch M, Rink M.
    Surg Oncol; 2019 Mar; 28():208-213. PubMed ID: 30851902
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Assessing the Impact of Time to Cystectomy for Variant Histology of Urothelial Bladder Cancer.
    Lin-Brande M, Pearce SM, Ashrafi AN, Nazemi A, Burg ML, Ghodoussipour S, Miranda G, Djaladat H, Schuckman A, Daneshmand S.
    Urology; 2019 Nov; 133():157-163. PubMed ID: 31421144
    [Abstract] [Full Text] [Related]

  • 18. Outcomes after urothelial recurrence in bladder cancer patients undergoing radical cystectomy.
    Mitra AP, Alemozaffar M, Harris BN, Schuckman AK, Skinner EC, Daneshmand S.
    Urology; 2014 Dec; 84(6):1420-6. PubMed ID: 25306479
    [Abstract] [Full Text] [Related]

  • 19. The impact of histological variants on outcomes after open radical cystectomy for muscle-invasive urothelial bladder cancer: results from a single tertiary referral centre.
    Naspro R, Finati M, Roscigno M, Pellucchi F, La Croce G, Sodano M, Manica M, Chinaglia D, Da Pozzo LF.
    World J Urol; 2021 Jun; 39(6):1917-1926. PubMed ID: 32696127
    [Abstract] [Full Text] [Related]

  • 20. Comparison of american joint committee on cancer pathological stage T2a versus T2b urothelial carcinoma: analysis of patient outcomes in organ confined bladder cancer.
    Boudreaux KJ, Clark PE, Lowrance WT, Rumohr JA, Barocas DA, Cookson MS, Smith JA, Chang SS.
    J Urol; 2009 Feb; 181(2):540-5; discussion 546. PubMed ID: 19084855
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.